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ADAMTS5 expressionwas downregulated in the miR-320c mimic group
and upregulated in the inhibitor group. Cell proliferative activity was
upregulated signiﬁcantly in the miR-193b inhibitor group compared
with the control group. We believe that miR-199a-3p and miR-193b are
involved in the senescence of chondrocytes and that miR-320c is
involved in the juvenile properties of chondrocytes.
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OA PHENOTYPE AND THERAPY
P. Conaghan. Univ. of Leeds, Leeds, United Kingdom
Purpose: There is a massive unmet need for effective osteoarthritis (OA)
therapies, both symptom and structure modifying. The application of
modern imaging modalities such as magnetic resonance imaging (MRI)
and ultrasound has led to ground-breaking advances in understanding of
the OA phenotype. As yet the revolution in disease knowledge has not
been mirrored by improved therapeutics, but increasingly the OA liter-
ature demonstrates a shift toward personalised, pathology-targeted
interventions. In typical symptomatic OA, modern imaging has demon-
strated abundant pathology; inﬂammation (visualised as synovitis) and
subchondral bone pathology are much more common than previously
considered. Synovitis has been reported extremely commonly, with
detection reﬂecting the sensitivity of the imaging tool employed.
Although generally less in volume and vascularity than in rheumatoid
arthritis (RA), the inﬂammatory cells and mediators present are very
similar. This imaging-detected synovitishas been associatedwith thepain
of OA, and also identiﬁed as an independent predictor of progression to
joint replacement. Of our current symptomatic pharmacological agents,
the 2with consistentlymodest analgesic effect sizes areNSAIDs and intra-
articular corticosteroids - both of which have signiﬁcant anti-inﬂamma-
tory actions. Oral corticosteroid at low dose failed to beneﬁt hand OA in a
recent RCT; however a larger dose did have analgesic effects in a knee OA
study. Disease modifying anti-rheumatic drugs are used in rheumatoid
arthritis (RA) for their effect on theprimary disease inﬂammatoryprocess,
resulting in reduction in symptoms and consequent retardation of
structural joint damage. Such DMARDs were historically not considered
for OA as it was not primarily an inﬂammatory arthritis. However a small,
open label study of methotrexate demonstrated analgesic efﬁcacy
equivalent to that of an NSAID. Trials targeting IL-1 with a number of
monoclonal antibody inhibitors have been disappointing in terms of
symptom control. Several recent studies have investigated the effects of
anti-TNF therapies in OA, with variable results. Studies of erosive hand OA
have resulted in reduced swollen joint counts and reduced structural
deterioration in joints with baseline clinical synovitis, but generally there
have been no sustained analgesic beneﬁts, though often anti-TNF therapy
was given for short duration. Fewer studies have been conducted in knee
OA, although a small number open-label study suggested good analgesic
response. MRI-identiﬁed bone marrow lesions (BMLs) have provided
insights intosubchondralbonearchitectural failure andare related toboth
pain and ipsilateral compartment progression of knee OA. A number of
pharmacological therapies with potential to positively affect trabecular
structure (as well as direct potential beneﬁts for cartilage) have recently
demonstrated beneﬁts in large OA trials, including calcitonin, strontium
andzoledronic acid; the latter2 therapieshave inparticulardemonstrated
reductions in BMLs and associated reductions in knee pain. These exciting
though relatively early attempts at phenotype-targeted therapies provide
the basis for strong growth in this ﬁeld, and improved molecular tissue
phenotyping should further enhance the range of targets and potential
therapeutics.
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NOVEL APPROACHES TO JOINT REPAIR
F. Guilak. Duke Univ. Med. Ctr., Durham, NC, United States
Purpose: The repair of articular cartilage following joint injury or
degeneration remains an important challenge for the ﬁeld of tissue
engineering. While a number of techniques have been developed over
the years for the treatment of small cartilage defects, there have been
few attempts at tissue-engineered therapies for end-stage osteo-
arthritis. Some of themajor considerations for this approach include the
identiﬁcation and characterization of an abundant and accessible cell
source as well as the design of biologically and mechanically functional
scaffolds that can withstand joint loading.Methods: Here we describe the engineering of large, anatomically-
shaped cartilage constructs using different stem cell sources (adipose
stem cells, mesenchymal stem cells, or induced pluripotent stem cells),
combined with mechanically functional cell-instructive scaffolds.
Under appropriate culture conditions, these stem cells exhibit a chon-
drogenic phenotype and can synthesize cartilage-speciﬁc matrix pro-
teins that are assembled in a functional extracellular matrix. An
important consideration in the long-term success of such tissue
replacements is a more thorough investigation of the inﬂuence of bio-
mechanical factors, such as the design and characterization of the
mechanical properties of biomaterial scaffolds and the use of bio-
physical stimuli to control cell differentiation and metabolism.
Results: Using principles of “functional tissue engineering”, we have
developed novel biomimetic scaffolds, based on techniques for three-
dimensional weaving of biocompatible ﬁbers, which can conform to
contoured surfaces. Such moldable composite scaffolds can be engi-
neered with initial properties that reproduce the anisotropy, viscoe-
lasticity, and tension-compression nonlinearity of native articular
cartilage, providing the potential for complete resurfacing of the entire
joint surface. The ability to control stem cell fate in vivo may provide
more direct approaches for translation of these tissue-engineering
techniques by minimizing ex vivo manipulation of cells and repair tis-
sues. In this regard, these textile processing techniques allow site-
speciﬁc delivery of proteins or genes to facilitate the formation of
complex inhomogenous tissues from a single cell source. Furthermore,
this method can be adapted to confer tunable and inducible immuno-
modulatory properties to stem cells for controlled drug delivery to the
joint.
Conclusions: Recapitulating the biomechanical properties of the tissue,
in addition to providing developmental, biophysical, and immunomo-
dulatory cues to the stem cells, may provide new advances in the
engineering of functional tissue replacements as a therapy for end-
stage osteoarthritis.
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STUDIES OF POST-TRAUMATIC OSTEOARTHRITIS-IMPLICATIONS FOR
UNDERSTANDING OF THE ROLE OF MECHANICAL FORCES IN THE
ONSET AND PROGRESSION OF OSTEOARTHRITIS
J.A. Buckwalter, J.A. Martin. Univ. of Iowa, Iowa City, IA, United States
Purpose: Excessive joint loadings, either single (acute contact stress) or
repetitive (cumulative contact stress), cause progressive joint degen-
eration and subsequent development of the clinical syndrome of
osteoarthritis (OA). Joint injuries causing acute excessive contact stress
are common and often affect young adults: each year one in 12 people
between the ages of 18-44 seeks medical attention for treatment of
joint injury, and more than 12% of all lower limb OA is caused by joint
trauma. Despite advances in surgical treatment and rehabilitation of
injured joints, the risk of OA following joint fractures has not decreased
in the last 50 years. For these reasons there is a critical need to advance
understanding of how mechanical forces cause progressive loss of
articular cartilage and the syndrome of osteoarthritis.
Methods: We have conducted a series of in vitro, in vivo and clinical
studies with the intent of discovering howacute and cumulative contact
stress cause osteoarthritis.
Results: Cumulative excessive articular surface contact stress that leads
to OA results from joint dysplasia, incongruity and instability, but also
may cause OA in patients without known joint abnormalities. Advances
in understanding of the thresholds for mechanical damage to articular
cartilage, and of the biologic mediators that cause progressive loss of
articular cartilage due to excessive mechanical stress, will lead to better
treatments of joint injuries and improved strategies for restoring
damaged joint surfaces. Recent in vitro investigations show that reactive
oxygen species (ROS) released from mitochondria following excessive
articular cartilage loading can cause chondrocyte death and matrix
degradation and reduce the ability of chondrocytes to respond normally
to physiologic loading. Alarmins released from damaged chondrocytes
trigger an inﬂammatory response that can cause loss of cartilage. Pre-
venting the release of ROS or inhibiting their effects preserves chon-
drocytes and their matrix. Blocking the effects of Alarmins decreases
the inﬂammatory response. Fibronectin fragments released from
articular cartilage subjected to excessive loads also stimulate matrix
degradation; inhibition of the molecular pathways initiated by these
fragments prevents this effect. Distraction and motion of osteoarthritic
articular surfaces in humans can promote joint remodeling, decrease
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matic OA. This result, combined with the observation that chon-
droprogenitor cells are active in osteoarthritic joints, suggests that
altered loading creates an environment that promotes beneﬁcial joint
remodeling.
Conclusions: Taken together, these recent advances in understanding
of how mechanical forces cause loss of articular cartilage, including
identiﬁcation of mechanically induced mediators of cartilage loss, and
of how changing joint loading can promote joint remodeling provide
the basis for new biologic andmechanical approaches to the prevention
and treatment of all forms of OA.
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RESEARCH TOOLS FOR THE STUDY OF ASPECTS OF THE EPIGENETICS
OF OSTEOARTHRITIS
I.M. Clark. Univ. of East Anglia, Norwich, United Kingdom
Osteoarthritis (OA) is a degenerative joint disease characterised by
degradation of articular cartilage as well as thickening of the sub-
chondral bone and the formation of osteophytes at the joint margin. The
aetiology of OA is complex with genetic, developmental, biochemical
and biomechanical factors contributing to the disease process. Aberrant
gene expression has clearly been shown in OA and epigenetic mecha-
nisms may contribute to this. Epigenetic modiﬁcations may include:
DNA methylation, histone modiﬁcations and non-coding RNA expres-
sion (both microRNA and long non-coding RNA). A number of studies
have compared epigenetic modiﬁcations in OA and normal tissues and
examined epigenetic mechanisms which impact upon the disease. Key
to dissecting the function of epigenetics in OA is the methodology by
which these changes can be measured. This workshop will explore
aspects of the research tools which can be used for the study of epi-
genetics in OA. It will discuss tools which are appropriate in either the
culture ﬂask, or in limiting tissue samples. The scale of the study is also
important since measuring genome wide changes requires different
approaches from determining a single epigenetic mark. Quantiﬁcation
may also be key where different technologies show degrees of accuracy
or linearity which may alter conclusions or require further validation.
The workshop is not a lecture on epigenetics and OA, but rather a dis-
cussion of the tools available for researchers to apply in this area and
their strengths and weaknesses.
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USING ZEBRAFISH TO PROBE THE GENETICS OF OSTEOARTHRITIS
L.H. Brunt y, J. Norton y, S. Reynolds y, E. Moro z, A. Hayes x, E. Rayﬁeld y,
C.L. Hammond y. yUniv. of Bristol, Bristol, United Kingdom; zUniv. of
Padova, Padova, Italy; xUniv. of Cardiff, Cardiff, United Kingdom
Purpose: The purpose of our work is to ascertain the extent to which
zebraﬁsh can be used as an animal model to dissect how osteoarthritis
susceptibility genes affect cell behaviour in the formation and main-
tenance of joints.
Methods: Using BAC recombineering we have generated a number of
transgenic lines in which ﬂuorescent reporters are expressed under the
control of promoters linked to cartilage biology, for example Type 2 and
Type X Collagens and Gdf5, as well as reporters for the activity of a
number of signalling pathways including Wnt and Hedgehog; allowing
us to visualise cell behaviour in real time in the translucent ﬁsh. We
have used a number of histological and immunohistochemical methods
along with electron microscopy and microCT to characterise a number
of events in zebraﬁsh cartilage development, joint formation and during
skeletal ageing. We have also generated Finite Element models that
allow us to visualise the biomechanical strains experienced in zebraﬁsh
jaw elements resulting from the action of their associated muscles.
Results: Using a combination of techniques we show that in the
zebraﬁsh normal joint morphogenesis requires muscle action, and
occurs through changes to cell organisation and orientation. We show
using Finite Element Analysis that positions of high biomechanical
strain in the zebraﬁsh joint overlap regions of high Wnt signalling
activity, and show that Wnt signalling is required downstream of
muscle activity for correct joint morphogenesis. We also show that
cartilage in ageing ﬁsh show a number structural and biochemical
changes some of which are reminiscent of those seen in osteoarthritis in
other animal models and in human cartilageConclusions: Taken together we conclude that zebraﬁsh can be a useful
animal model to dissect the role of osteoarthritis susceptibility genes in
the behaviour of chondrocytes during joint development, homeostasis
and ageing in normal and pathological situations.
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PROTEOMICS AND BIOMARKERS IN OSTEOARTHRITIS
A.O. Aliprantis, S. Ritter. Brigham and Women’s Hosp., Boston, MA, United
States
Purpose: The application of modern proteomic techniques to disease
states affords the opportunity to identify deregulated pathways that
contribute to pathogenesis. These discoveries in turn may lead to new
therapeutic targets, as well as “wet” biomarkers that aid in diagnosis,
prognosis and the prediction of treatment responses. Building on the
concept that osteoarthritis (OA) is a disease of all joint structures
(synovium, cartilage and bone), and that synovial ﬂuid (SF) may rep-
resent of synthesis of inputs from these structures, we compared the
proteomic proﬁle of knee joint SF from patients with early and late stage
OA to unaffected controls by 2-dimensional gel electrophoresis and
mass spectrometry. In our recent publication, using this relatively
unbiased approach, 66 proteins were reported as differentially repre-
sented in healthy vs. OA SF (1). Pathway analysis identiﬁed three bio-
logic processes among these proteins: the complement and coagulation
systems and the acute phase response. Interestingly, early and late OA
manifested a very similar proteomic proﬁle. Together, these ﬁndings
suggest the osteoarthritic disease processes involves activation of
inﬂammatory pathways that are well-established by the time patients
are diagnosed. This presentation will explore 1) the relative con-
tribution of joint tissues to the SF OA proteome, including cartilage and
synovium, 2) how proteomics can illuminate the pathogenesis of OA to
identify therapeutic targets, 3) validation of proteomic discovery ﬁnd-
ings using multiplexed selected reaction monitoring (SRM) mass
spectrometry peptide assays and 4) translation of SF protein biomarkers
to quantitative serum based assays to predict disease progression in OA
patients. At the end of this presentation, attendees should understand
some of the major protein constituents of OA SF and how knowledge of
this proteome may inform pathogenesis and biomarker development
for this difﬁcult disease.
1. Ritter SY, Subbaiah R, Bebek G, Crish J, Scanzello CR, Krastins B,
Sarracino D, Lopez MF, Crow MK, Aigner T, Goldring MB,
Goldring SR, Lee DM, Gobezie R, and Aliprantis AO. Proteomic
analysis of synovial ﬂuid from the osteoarthritic knee: com-
parison with transcriptome analyses of joint tissues. Arthritis
Rheum 2013;65:981–992.
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HOW LIFESTYLE FACTORS INFLUENCE THE DEVELOPMENT AND
PROGRESSION OF OA
D. Dunlop. Northwestern Univ., Chicago, IL, United States
Purpose: Osteoarthritis (OA) is the most commonworldwide disease of
joints and its prevalence is growing. The worldwide obesity epidemic in
older adults is fueling an increase in many chronic diseases, including
osteoarthritis. This presentation will focus on knee OA, which is the
most prevalent form of OA and a major cause of arthritis-related
functional loss and disability.
The American College of Rheumatology 2012 recommendations rec-
ognize lifestyle factors, including weight loss and physical activity, as
primary nonpharmacologic therapies for OA. Obesity has long been a
recognized risk factor for the development of knee OA. Obesity con-
tributes to OA through joint load, altered gait, and impaired muscle
performance. Importantly weight inﬂuences the course of disease
progression. Longitudinal cohort data provide evidence for a dose
response relationship between weight change and function. Notably,
45% of adults with a weight loss 10% had a clinically meaningful
improvement in WOMAC function. Randomized controlled clinical tri-
als (RCT) support the effectiveness of weight loss to improve function in
adults with knee OA. RCT evidence in obese knee OA patients demon-
strated a 10% weight loss% could improve self-reported function by
more than 25%.
